Dyspnea News and Research

RSS

Dyspnea or dyspnoea or shortness of breath is a debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations.

Inhaler misuse linked to cognitive impairment and poor manual dexterity

Cognitive function, hand dexterity, and breathing ability play an important role in helping people with chronic obstructive pulmonary disease (COPD) use their inhalers correctly, according to a new study.

9 Jul 2026

Obesity makes breathing harder during exercise for young vapers

E-cigarette users with obesity show higher ventilatory demands and breathlessness during exercise, indicating potential long-term respiratory health risks.

30 Jun 2026

Soy-based nutrients may help reduce COPD symptom burden

Higher isoflavone consumption is associated with improved respiratory health in former smokers with COPD, highlighting diet's role in disease management.

28 Apr 2026

High-dose curcumin fails to produce lasting gut-microbiome changes in IBD patients

In an open-label study of 29 men, including patients with ulcerative colitis and Crohn’s disease in remission, 6 g per day of curcumin for eight weeks led to modest, transient shifts in gut microbiota composition without sustained restructuring. Despite achieving high fecal concentrations and minimal systemic bioavailability, curcumin did not produce durable microbiome changes, and disease activity scores remained stable.

2 Mar 2026

COVID-19 ARDS survivors face lasting disability and high late mortality, researchers report

In this single-center ambispective cohort of 283 Polish patients with COVID-19–related ARDS requiring invasive mechanical ventilation, cumulative mortality reached 44.5% at four years after ICU admission. Among survivors, substantial proportions reported persistent functional limitations, insomnia, fatigue, and reduced quality-adjusted life years.

2 Mar 2026

Sprint-based exercise reduces panic attacks and improves mental health

High-intensity exercise shows promise in retraining fear responses in panic disorder, providing a sustainable and engaging alternative to traditional therapies.

11 Feb 2026

Analyzing the role of smoking in viral recovery

COVID-19 brought about lasting changes that are still being felt today in the post-pandemic era, with one being the unprecedented side effect known as Long COVID.

27 Jan 2026

Long COVID symptom clusters that could reshape patient care

A systematic review of Long COVID identifies symptom clusters, highlighting fatigue and proposing a management framework for personalized treatment strategies.

12 Jan 2026

Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving treatment adherence in the PIONEER trial.

7 Jan 2026

RSV can have profound, long-lasting effects in hospitalized adults

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

11 Dec 2025

Poor lung gas exchange may help explain lingering brain symptoms in Long COVID

This study found that people with Long COVID more than two years after infection showed normal lung tests and brain structure, yet reported significant sleep and cognitive symptoms. Subtle correlations revealed that poorer lung gas exchange was linked with higher brain perfusion, worse sleep, and weaker executive function, suggesting a possible lung–brain connection.

25 Nov 2025

Death risk found to be six times higher among hospitalized patients with dyspnea

The risk of dying is six times higher among patients who become short of breath after being admitted to hospital, according to research published today (Monday) in ERJ Open Research. Patients who were in pain were not more likely to die.

10 Nov 2025

Harvard researchers augment LLM to create expert diagnostic system

Except for one key aspect, the setup is a familiar one in medicine: An expert diagnostician presents a particularly challenging case to a roomful of colleagues, carefully walking them through the patient's symptoms and initial test results.

10 Oct 2025

Portable ultrasound improves diagnosis and patient outcomes

When hospitalized patients struggle to breathe, doctors typically reach for their stethoscopes, but results from a Rutgers and RWJBarnabas Health clinical study in JAMA Network Open suggest they should diagnose the problem with portable ultrasounds instead.

5 Sep 2025

Global experts release guidance on CT imaging for post-COVID lung abnormalities

Experts representing multiple societies and institutions across 14 countries have published guidance for computed tomography (CT) imaging in patients with residual lung abnormalities after COVID-19 illness.

22 Jul 2025

Home rehab program improves lung function in bronchiectasis

Findings reveal that a structured home rehabilitation program boosts lung function and quality of life in bronchiectasis patients, reducing acute exacerbations.

18 Jul 2025

Study finds higher rates of pulmonary embolism in pediatric patients

Pulmonary embolism in children has been acknowledged to be an issue in clinical care but was thought to be rare.

20 May 2025

COVID-19 leaves longer-lasting symptoms than flu or pneumonia, study finds

A large U.S. cohort study found that post-acute symptoms after COVID-19 vary by initial disease severity, age, sex, and comorbidities. Compared to influenza and pneumonia, long COVID presented with distinct symptom patterns and longer-lasting effects.

1 May 2025

Targeted rehab exercises improve lung health and mobility in long COVID patients

Pulmonary rehabilitation significantly improves physical capacity, lung function, and quality of life in long COVID patients, with the greatest benefits seen in 4-8 week programs combining breathing and multicomponent exercises.

20 Mar 2025

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for adults with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy, irrespective of PD-L1 expression level or tumor histology.

14 Feb 2025